Maninder Hora
2018
In 2018, Maninder Hora earned a total compensation of $3.8M as Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer at Nektar Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $464,900 |
|---|---|
| Option Awards | $1,516,746 |
| Salary | $489,417 |
| Stock Awards | $1,350,866 |
| Other | $17,513 |
| Total | $3,839,442 |
Hora received $1.5M in option awards, accounting for 40% of the total pay in 2018.
Hora also received $464.9K in non-equity incentive plan, $489.4K in salary, $1.4M in stock awards and $17.5K in other compensation.
Rankings
In 2018, Maninder Hora's compensation ranked 2,926th out of 14,244 executives tracked by ExecPay. In other words, Hora earned more than 79.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,926 out of 14,244 | 80th |
Division Manufacturing | 1,074 out of 5,765 | 81st |
Major group Chemicals And Allied Products | 372 out of 2,128 | 83rd |
Industry group Drugs | 305 out of 1,817 | 83rd |
Industry Pharmaceutical Preparations | 232 out of 1,391 | 83rd |
Source: SEC filing on April 30, 2019.
Hora's colleagues
We found four more compensation records of executives who worked with Maninder Hora at Nektar Therapeutics in 2018.